Create your profile now and gain access to exclusive deals and high-potential startups.


Massachusetts-based pharmaceutical company specializing in non-opioid pain therapies.
Solace Pharmaceuticals: Boston-based provider of therapeutic solutions for chronic pain.

US-based Centrexion Therapeutics develops non-opioid, non-addictive therapies for chronic pain treatment.

Trigemina, Inc.: A US-based pharmaceutical company innovating non-opiate pain therapies.
Innovative cancer diagnostics biotech in Beverly Hills.

BloodQ offers personalized cancer treatment through its innovative diagnostic platform analyzing circulating DNA.
OncoHealth: Innovating cancer detection with diagnostic testing and screening devices.
OncoCellMDx: A Corvallis-based medical firm innovating noninvasive diagnostic tests for cancer severity.

Metaphore Biotechnologies: Unveiling revolutionary therapies through biomimicry and machine learning.

Faze Medicines: A pioneering biotech company specializing in biomolecular condensate therapeutics.

Frontier Medicines, a US-based precision medicine firm, pioneers in developing treatments for previously undruggable diseases.

Ampersand Biomedicines: Innovating disease-targeted programming therapeutics via our AND™ Platform.

US-based Lysosomal Therapeutics Inc innovates in neurodegeneration research, developing treatments for severe neurological diseases.

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.
Boston-based medical organization developing therapeutics for neurodegenerative diseases.

APRINOIA: A global biotech leader in precision neuroscience, innovating diagnostic tools and therapies for neurodegenerative diseases.

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.
US-based Karyopharm Therapeutics offers oncology-focused pharmaceutical solutions, specializing in multiple myeloma treatments.
Bonum Therapeutics: A tech platform innovating treatments for cancer and various diseases.
Nirogy Therapeutics: Innovating small molecule drugs to target cellular transporters and disrupt tumor growth.
Boston-based medical research company developing small molecule therapeutics since 2019.